Dr. Stein's research is focused on Acute and Chronic Leukemias, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Development of Novel Therapies for AML. He is working to develop new therapies — such as small molecule inhibitors — that can more precisely and effectively target AML. His goal as a doctor and researcher is to help people with AML and other blood cancers have the best possible outcomes.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals

Follow Us

facebook instagram twitter youtube


Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect


Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811